ClinicalTrials.govpublic full text
A Study to Evaluate NT219 Alone and in Combination with ERBITUX® (Cetuximab) in Adults with Advanced Solid Tumors and Head and Neck Cancer
solid tumor, adult, squamous cell carcinoma of head and neck, colorectal adenocarcinoma, metastatic solid tumor, recurrent solid tumor, head and neck cancer, nt219, erbitux, cetuximab, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838885
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.